RVL Pharmaceuticals plc Quarterly Payments to Acquire Property, Plant, and Equipment in USD from Q1 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
RVL Pharmaceuticals plc quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2018 to Q1 2023.
  • RVL Pharmaceuticals plc Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2023 was $1.3M, a 4730% increase year-over-year.
  • RVL Pharmaceuticals plc annual Payments to Acquire Property, Plant, and Equipment for 2022 was $752K, a 57.8% decline from 2021.
  • RVL Pharmaceuticals plc annual Payments to Acquire Property, Plant, and Equipment for 2021 was $1.78M, a 39% decline from 2020.
  • RVL Pharmaceuticals plc annual Payments to Acquire Property, Plant, and Equipment for 2020 was $2.92M, a 26.3% decline from 2019.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.3M +$1.28M +4730% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $27K -$395K -93.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $422K -$527K -55.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $949K +$314K +49.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $635K -$802K -55.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $1.44M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.